Rhabdomyolysis and AKI Following Atorvastatin-Gemfibrozil Rhabdomyolysis and AKI Following Atorvastatin-Gemfibrozil

This case report demonstrates that severe rhabdomyolysis due to statins with or without fibrates may occur with few clinical symptoms and signs, even many weeks after discontinuation of therapy.Journal of Medical Case Reports
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Related Links:

CONCLUSIONS: In this large cohort of hospitalized COVID-19 patients, statins were not independently associated with all-cause mortality during follow-up. Clinically relevant statin-associated adverse effects should be carefully monitored during hospital admission.PMID:34511251 | DOI:10.1016/j.medcli.2021.07.003
Source: Medicina Clinica - Category: General Medicine Authors: Source Type: research
The objectives would be to prevent liver-related morbidity and mortality rather than treating cirrhosis complications to take additional information that makes it possible to add statins to the standard of care of these patients.PMID:34366626 | PMC:PMC8326251 | DOI:10.3748/wjg.v27.i28.4639
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Source Type: research
More News: Atorvastatin Calcium | Cholesterol | Gemfibrozil | Health | Lipitor | Primary Care | Rhabdomyolysis | Statin Therapy | Zivast